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Abstract  26	  
This study investigates effects of genotype on responses to alternative feeds in Atlantic salmon. 27	  
Microarray analysis of the liver transcriptome of two family groups, Lean or Fat, fed a diet 28	  
containing either fish oil (FO) or a vegetable oil (VO) blend indicated that pathways of cholesterol 29	  
and lipoprotein metabolism might be differentially affected by diet depending on the genetic 30	  
background of the fish, and this was further investigated by RT-qPCR, plasma and lipoprotein 31	  
biochemical analysis. Results indicate a reduction in VLDL and LDL levels, with no changes in 32	  
HDL, when FO is replaced by VO in the Lean family group, whereas in Fat fish fed FO levels of 33	  
apoB-containing lipoproteins were low and comparable to those fed VO in both family groups. 34	  
Significantly lower levels of plasma triacylglycerol (TAG) and LDL-TAG were measured in the Fat 35	  
group, that were independent of diet, whereas plasma cholesterol was significantly higher in fish fed 36	  
the FO diet in both groups. Hepatic expression of genes involved in cholesterol homeostasis, β-37	  
oxidation and lipoprotein metabolism showed relatively subtle changes. Significantly lower 38	  
expression of genes considered anti-atherogenic in mammals (ABCA1, apoAI, SR-BI, LPLb and 39	  
LPLc) was found in Lean fish, compared with Fat, when fed VO. Furthermore, the Lean family 40	  
group appeared to show a greater response to diet composition in the cholesterol biosynthesis 41	  
pathway, mediated by SREBP2. Finally, the presence of 3 different transcripts for lipoprotein lipase 42	  
(LPL), with differential patterns of nutritional regulation, was demonstrated.  43	  
 44	  
 45	  
As worldwide demand for seafood continues to grow and traditional fisheries are at best stable or 46	  
in decline, aquaculture production will need to bridge the gap. An inevitable outcome of growing 47	  
marine aquaculture production, associated with reduced availability of raw materials from wild 48	  
fisheries, has been the need to look for more sustainable alternatives to replace fish oil (FO) and fish 49	  
meal (FM) in aquafeed formulations. Recent estimates suggest that 88.5% of global production of 50	  
FO is currently used by the aquaculture sector, with salmonid culture taking the largest share (56% 51	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of total FO production) (1). Insufficient FM and FO supply may seriously limit aquaculture growth 52	  
and so future activity depends on reduced dependency on FO and its replacement with alternative 53	  
oils, while maintaining fish welfare and health benefits for the human consumer. Extensive studies 54	  
have shown that VOs can replace up to 100% of FO in salmonid diets without compromising fish 55	  
growth or condition, but above 50% of FO replacement a significant reduction is observed in tissue 56	  
levels of n-3 long-chain polyunsaturated fatty acids (LC-PUFA), namely eicosapentaenoic acid 57	  
(EPA) and docosahexaenoic acid (DHA), diminishing the beneficial, health-promoting, nutritional 58	  
profile for human consumption (2-4). There is now evidence that flesh n-3 LC-PUFA level is a 59	  
heritable trait in Atlantic salmon (5). This being the case, combining genetic selection with changes 60	  
in commercial diet formulations (i.e., high levels of FM and FO replacement) might be a viable 61	  
strategy to meet worldwide growing demands for aquaculture products. Therefore, in order to 62	  
investigate the feasibility of this approach, large-scale studies exploring diet formulation × genotype 63	  
interactions are essential. This was the overarching objective of the present study, which 64	  
investigated the effect of genotype on responses to alternative feeds where FO was replaced by VO 65	  
in Atlantic salmon.  66	  
Early studies on dietary FO replacement in salmon suggested that high inclusion levels of certain 67	  
VO might negatively affect fish health and resistance to stress by changing cardiac membrane fatty 68	  
acid composition, and diets containing sunflower oil were reported to result in considerable 69	  
cardiomyopathy, extensive thinning and necrosis of the ventricular muscle wall (6,7). Other studies 70	  
could not directly show an involvement of dietary fatty acid composition on the development of 71	  
arteriosclerotic changes in Atlantic salmon but could not exclude it either (8). This is therefore an 72	  
area that is still open for discussion. On the other hand, a relationship between nutritional factors, 73	  
especially dietary level of n-3 LC-PUFA, and risk of developing atherosclerosis has been well 74	  
demonstrated in mammals and, furthermore, genetic polymorphisms/variants have been identified 75	  
in several genes involved in cholesterol and lipoprotein metabolism that can explain different 76	  
susceptibilities and responses to diet (9-12). No such associations have been reported in fish, where 77	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knowledge is still quite fragmentary. Therefore, the specific aim of the current study was to further 78	  
explore the potential influence of dietary oil source on cholesterol and lipoprotein metabolism, 79	  
which may ultimately affect propensity to develop cardiac lesions, in Lean and Fat family groups of 80	  
Atlantic salmon, differing in flesh adiposity (13) by quantifying the gene expression of key genes 81	  
informed by a microarray analysis of the hepatic transcriptome. 82	  
 83	  
Methods 84	  
 85	  
Feeding trial and sampling 86	  
A trial was conducted using two genetically characterised and contrasting groups of Atlantic 87	  
salmon (Salmo salar) post-smolts comprising full-sib families selected from the Landcatch Natural 88	  
Selection Ltd (LNS) breeding program (Argyll, Scotland). Choice was based on estimated breeding 89	  
values (EBVs) of the parents for high or low flesh adiposity, assessed by Torry Fatmeter (Distell 90	  
Industries, West Lothian, UK), a trait with heritability ranging from 0.17 to 0.39 in this dataset. The 91	  
two groups were created from four unrelated full-sib families; two families from the extreme lower 92	  
end of the EBV distribution for flesh lipid content (“Lean”) and two families from the extreme 93	  
upper end of the distribution (“Fat”). The average EBV for the lipid content of the two Fat families 94	  
was 2.00 percentage units higher than that of the two selected Lean families, representing a 95	  
standardised selection differential of 2.33 standard deviations (sds). 96	  
Two thousand fish of each group were stocked into eight 12 x 5m3 net pens at the Ardnish Fish 97	  
Trials Unit (Marine Harvest Scotland, Lochailort, Scotland; 500 fish pen-1). Each group was fed one 98	  
of two experimental diets (Skretting ARC, Stavanger, Norway) formulated to fully satisfy the 99	  
nutritional requirements of salmonid fish for 55 weeks until reaching ~3 kg. Duplicate pens of each 100	  
group were fed a similar basal diet containing 25-32% fish meal and 40-45% plant meals, and 27.5-101	  
30% oil supplied either as northern fish oil (FO) or as a vegetable oil (VO) blend comprising 102	  
rapeseed, palm and Camelina oils in a ratio of 5:3:2. Diets contained similar levels of PUFA 103	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(around 31%) but different n-3 and n-6 contents, 25.3% and 4.6% in the FO diet and 13.4% and 104	  
17.1% in the VO diet of PUFA, respectively. Further details of the trial including diet formulations, 105	  
and proximate and fatty acid compositions of the feeds can be found in Bell et al. (13).  106	  
At 55 weeks, 25 fish were sampled per pen, killed by a blow to the head following anaesthesia 107	  
using MS222. Samples of liver were collected for molecular analyses and stored at -80ºC. 108	  
Additionally, ten samples of liver and flesh (Norwegian Quality Cut) were collected per pen and 109	  
stored at -20oC pending biochemical analysis. Four pools comprising 5 fish/pool were prepared for 110	  
flesh and liver lipid analyses from the duplicate pens per family and diet (13). Blood was collected 111	  
from the caudal vein using EDTA vacutainers from 5 fish per pen and centrifuged at 3000 × g for 112	  
10 min to obtain plasma fractions, which were then pooled for lipoprotein analysis. Experimental 113	  
procedures complied with the UK Home Office code of practice for the care and use of animals for 114	  
scientific purposes and all protocols were approved by the Institute of Aquaculture and University 115	  
of Stirling ethics committees. There were no aspects of this trial that would cause aggravated or 116	  
unnecessary harm or stress to the fish. 117	  
 118	  
RNA extraction and purification 119	  
Liver tissue (0.2 g) from six individuals per group was homogenised in 2mL of TRI Reagent 120	  
(Ambion, Applied Biosystems, Warrington, U.K.). Total RNA was isolated following 121	  
manufacturer’s instructions, 100µg were further purified by mini spin-column (RNeasy Mini Kit, 122	  
Qiagen, Crawly, UK), and RNA quality and quantity assessed by gel electrophoresis and 123	  
spectrophotometry (NanoDrop ND-1000, Thermo Scientific, Wilmington, U.S.A.).  124	  
 125	  
Microarray hybridisations and analysis 126	  
The TRAITS/SGP (v.2.1) salmon 17k cDNA microarray was used in this experiment 127	  
(ArrayExpress accession: A-MEXP-1930) (14). A dual-labelled experimental design was employed 128	  
for the microarray hybridisations. Each experimental sample was competitively hybridised against a 129	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common pooled-reference, obtained with equal amounts of all samples, which permits valid 130	  
statistical comparisons across all treatments to be made. The entire experiment comprised 24 131	  
hybridisations - 2 lipid phenotype groups (Lean/Fat) × 2 diets (FO/VO) × 6 biological replicates. 132	  
Antisense amplified RNA (aRNA) was produced from each total RNA isolation using the Amino 133	  
Allyl MessageAmpTM II aRNA Amplification Kit (Ambion, Applied Biosystems), following the 134	  
manufacturer’s methodology, followed by Cy3 or Cy5 fluor incorporation through a dye-coupling 135	  
reaction. Briefly, 500 ng of total RNA were amplified and column-purified according to 136	  
manufacturer’s instructions including a 17 h transcription step, and aRNA quantified and quality 137	  
assessed as above. Cy dye suspensions (Cy3 & Cy5) in sufficient quantity for all labelling reactions 138	  
were prepared by adding 36 µL high purity dimethyl sulphoxide (Stratagene, Hogehilweg, The 139	  
Netherlands) to each tube of Cy dye (PA23001 or PA25001, GE HealthCare, Little Chalfont, UK). 140	  
To attach the Cy dyes, 3 µg each aRNA sample was suspended in 6 µL nuclease-free H2O and 141	  
heated to 70 ºC for 2 min. When cooled to room temperature, 2 µL of coupling buffer (0.5 M 142	  
NaHCO3; pH 9.2) and 2 µL of Cy3 dye suspension stock was added and then incubated for 1 h at 143	  
25ºC in the dark.  For labelling the common pooled reference sample with Cy5, a scaled-up reaction 144	  
was similarly performed. Unincorporated dye was removed by column purification (Illustra 145	  
AutoSeq G-50 spin columns; GE Healthcare). Dye incorporation and aRNA yield were quantified 146	  
by spectrophotometry (NanoDrop ND-1000) and quality controlled by separating 0.4 µL on a thin 147	  
mini-agarose gel and visualising products on a fluorescence scanner (Typhoon Trio, GE 148	  
Healthcare). 149	  
Microarray hybridisations were performed in a Lucidea semi-automated system (GE Healthcare), 150	  
without a pre-hybridisation step. For hybridisation of each array, each labelled biological replicate 151	  
and corresponding pooled reference (40 pmol each dye, c. 150 ng aRNA) were combined and 152	  
volume made up to 25 µL with nuclease-free water. After heating the aRNA at 95 ºC for 3 min in a 153	  
thermocycler, 225 µL of pre-heated (60 ºC) hybridisation solution, comprising 185 µL 0.7X 154	  
UltraHyb buffer (Ambion), 20 µL poly(A) at l0 mg/mL (Sigma-Aldrich, Dorset, UK), 10 µL 155	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herring sperm at c. 10 mg/mL (Sigma-Aldrich) and 10 µL ultra pure BSA at 10 mg/mL (Sigma-156	  
Aldrich), was added and the mixture kept at 60 ºC in the dark until being applied to the microarray. 157	  
After loading the slides and hybridisation solution into the Lucidea chambers (heated at 60 ºC), 158	  
chamber temperature was raised to 70 ºC for 10 min and then lowered to 42 ºC, at which 159	  
temperature hybridisation was continued for 17 h with pulse mixing every 15 min. Two post-160	  
hybridisation automatic washes (800 µL per slide at 8 µL/s) were performed with 1.0× SSC; 0.1% 161	  
SDS (wash 1) and 0.3× SSC; 0.2% SDS (wash 2), after which temperature was lowered to 40 ºC. 162	  
Slides were then manually washed using the EasyDipTM Slide staining system (Canemco Inc., 163	  
Quebec, Canada): 2 times with wash 2 solution for 3 min each (125 rpm; 45 ºC), followed by 3 164	  
times with 0.2× SSC for 2 min each (125 rpm; 45 ºC) and a final 20 s dip (room temperature) in 165	  
0.1× SSC. Slides were then dried by centrifugation (500 ×g for 5 min) and kept in a desiccator, in 166	  
the dark, before scanning.  167	  
Scanning was performed at 10 µm resolution using an Axon GenePix 4200AL Scanner (MDS 168	  
Analytical Technologies, Wokingham, Berkshire, U.K.). Laser power was kept constant (80%) and 169	  
the “auto PMT” function within the acquisition software (v.4) was enabled to adjust PMT for each 170	  
channel such that less than 0.1% of features were saturated and that the mean intensity ratio of the 171	  
Cy3 and Cy5 signals was close to one. BlueFuse software (BlueGnome, Cambridge, U.K.) was used 172	  
to identify features and extract fluorescence intensity values from the resultant TIF images. 173	  
Following a manual spot removal procedure and fusion of duplicate spot data (BlueFuse proprietary 174	  
algorithm), the resulting fluorescence intensity data and quality annotations for the 17,102 gene 175	  
features were exported into the GeneSpring GX version 10.0.2 analysis platform (Agilent 176	  
Technologies, Wokingham, Berkshire, U.K.) after undergoing a block Lowess normalisation. All 177	  
control features were excluded from subsequent analyses. Data transformation and quality filtering 178	  
were as follows: (a) all intensity values <1 were set to 1 and (b) data were filtered using a Blue-Fuse 179	  
spot confidence value >0.3 in at least 75 % of the values in any 2 out of 4 conditions and BlueFuse 180	  
spot quality of ≥0.5 in at least 75 % of the values in any 2 out of 4 conditions. This gave a list of 181	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14,772 genes eligible for statistical analysis. Experimental annotations complied fully with 182	  
minimum information about a microarray experiment (MIAME) guidelines (15). The experimental 183	  
hybridisations are archived on the EBI ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) 184	  
under accession number E-TABM-1089. No multiple test correction was employed as previous 185	  
analyses, confirmed by RT-qPCR, indicate that such corrections are over-conservative for this type 186	  
of data (16). Hybridisation data were analysed by two-way ANOVA, which examined the 187	  
explanatory power of the variables ‘diet’ and ‘family’ and the interaction between the two, at a 188	  
significance level of 0.05. In the present study we focussed on lipid metabolism genes whose 189	  
expression was differentially affected by diet (FO replacement by VO) depending on fish 190	  
leanness/fatness and thus only data from the significant interaction list is presented. 191	  
 192	  
RT-qPCR 193	  
Expression of selected genes showing a significant diet × family interaction in the microarray 194	  
analysis, and other genes relevant to lipid metabolic pathways, was studied by reverse transcription 195	  
quantitative real time PCR (RT-qPCR). Primers were either found in literature or designed from 196	  
EST sequences using Primer3 software (http://biotools.umassmed.edu/bioapps/primer3_www.cgi) 197	  
(Table 1). Amplification of three potential reference genes, cofilin-2, elongation factor-1α (elf-1α) 198	  
and β-actin, was performed but only cofilin-2 expression proved to be stable across treatments.  199	  
For RT-qPCR, one µg of column-purified total RNA per sample was reverse transcribed into 200	  
cDNA using the VersoTM cDNA kit (ABgene, Surrey, U.K.), following manufacturer’s 201	  
instructions, using a mixture of random hexamers and anchored oligo-dT (3:1, v/v). Negative 202	  
controls (no enzyme) were performed to check for genomic DNA contamination. cDNA was then 203	  
diluted 20-fold with water, after a similar amount of cDNA was pooled from all samples. RT-qPCR 204	  
analysis used relative quantification with the amplification efficiency of the primer pairs assessed 205	  
by serial dilutions of the cDNA pool. qPCR amplifications were carried out in duplicate (Quantica, 206	  
Techne, Cambridge, U.K.) in a final volume of 20 µL containing either 5 µL (for most genes) or 2 207	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µL (for the reference genes and other highly expressed genes) diluted (1/20) cDNA, 0.5 µM of each 208	  
primer and 10 µL AbsoluteTM QPCR SYBR® Green mix (ABgene). Amplifications were carried 209	  
out with a systematic negative control (NTC). The qPCR profiles contained an initial activation step 210	  
at 95 °C for 15 min, followed by 30 to 40 cycles: 15 s at 95 °C, 15 s at the specific primer pair 211	  
annealing Tm (Table 1) and 15 s at 72 °C. After the amplification phase, a melt curve of 0.5 °C 212	  
increments from 75 ºC to 90 °C was performed, confirming amplification of single products. RT-213	  
qPCR product sizes were checked by agarose gel electrophoresis and identities confirmed by 214	  
sequencing. Non-occurrence of primer-dimer formation in the NTC was also verified. Results were 215	  
analysed using the relative expression software tool (REST 2008, http://www.gene-216	  
quantification.info/), which employs a pair wise fixed reallocation randomisation test (10,000 217	  
randomisations) with efficiency correction (17), to determine the statistical significance of expression 218	  
ratios (or gene expression fold-changes) between two treatments. 219	  
 220	  
Plasma and lipoprotein lipid analysis 221	  
Plasma and lipoprotein lipids were analysed by means of a clinical bioanalyser (Maxmat PL 222	  
analyzer, Montpellier, France). Very low density lipoprotein (VLDL), low density lipoprotein 223	  
(LDL) and high density lipoprotein (HDL) in plasma were obtained by sequential centrifugal 224	  
flotation (18,19) as described by Lie et al. (20) at 197 600 × g and 4°C (Beckman OptimaTMXL-100K 225	  
Ultracentrifuge and SW41Ti rotor). Density intervals were obtained by addition of solid KBr (21), 226	  
and run time for separation of lipoproteins was: VLDL, d<1.015 g/mL for 20 h; LDL, 1.015 g/mL  227	  
< d < 1.085 g/mL  for 20 h and HDL, 1.085 g/mL  < d < 1.21 g/mL  for 44 h.  228	  
 229	  
Lipid class analyses 230	  
Total lipids were extracted from flesh or liver according to Folch et al. (22) and tissue lipid class 231	  
compositions determined by single-dimension double-development high-performance thin-layer 232	  
chromatography (HPTLC) and densitometry as described previously (23). 233	  
10	  
	  
 234	  
Statistical analysis 235	  
Differences in lipid class composition in liver and flesh and in levels of cholesterol and 236	  
triacylglycerol (TAG) in plasma and lipoproteins were assessed by two-way analysis of variance 237	  
(ANOVA), at a significance level of p<0.05. The RT-qPCR data were analysed both using the 238	  
ΔΔCt method with efficiency correction in REST and by two-way ANOVA of normalised gene 239	  
expression values obtained from the standard curve performed with cDNA serial dilutions.   240	  
 241	  
Results 242	  
 243	  
Microarray data 244	  
In order to identify genes involved in lipid metabolic processes whose expression is dependent 245	  
on the combined effects of both diet and family, i.e., for which the effect of diet depends on family, 246	  
the two-way ANOVA interaction list obtained from the analysis of the microarray data was 247	  
examined. This list contained 529 features that were significantly differentially regulated of which 248	  
17 features (corresponding to 15 genes) were related to lipid metabolism (Table 2). The top 100 249	  
genes, sorted by p-value, were categorised according to function and the lipid metabolism category 250	  
corresponded to 15 % of the total annotated genes (and excluding genes of miscellaneous function). 251	  
The lipid metabolism genes found in the interaction list can be broadly described as being involved 252	  
in the following processes: cholesterol/ isoprenoid biosynthesis (IPI-isopentenyl-diphosphate 253	  
isomerise, SQLE-squalene monooxygenase/epoxidase and ACAT2-acetyl-CoA acetyltransferase 2), 254	  
cholesterol transport/cellular efflux (ABCA1-ATP-binding cassete transporter A1), lipoprotein 255	  
metabolism (Angptl4-angiopoietin-like 4, LPL-lipoprotein lipase, EL-endothelial lipase), β-256	  
oxidation (CRAT-carnitine O-acetyltransferase, ECH1-delta3,5-delta2,4-dienoyl-CoA isomerase 257	  
and ECHS1-enoyl Coenzyme A hydratase 1), fatty acid synthesis (Δ5 and Δ6 fatty acyl desaturase, 258	  
Fad) and transport (ACBP-acyl-Coenzyme A-binding protein), glycerophospholipid/ 259	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phosphatidylcholine (PC) biosynthesis (PEMT-phosphatidylethanolamine N-methyltransferase) and 260	  
regulation of energy metabolism through switch on/off of multiple catabolic/anabolic pathways 261	  
(AMPK-5'-AMP-activated protein kinase subunit gamma-3).  262	  
 263	  
RT-qPCR analysis of gene expression 264	  
Relative gene expression of a series of genes involved in some of the preponderant lipid 265	  
metabolism pathways mentioned above, mostly associated to cholesterol biosynthesis and its 266	  
regulation and transport, fatty acid β-oxidation and lipoprotein metabolism, was determined by RT-267	  
qPCR (Table 3). This included some genes found in the significant interaction list from the 268	  
microarray analysis (IPI, ABCA1, EL and LPL). Although the fold-changes obtained by both 269	  
methods (microarray and RT-qPCR) differed, the general trend was similar for both IPI and 270	  
ABCA1. In the case of IPI, although differences were not statistically significant there was a clear 271	  
trend for it to be up-regulated when VO replaced FO in the diet in the Lean fish and down-regulated 272	  
in the Fat group. This difference appears to result from a lower expression of IPI in Lean fish, 273	  
compared to Fat, when they are fed the FO-diet. In contrast, the opposite was observed with 274	  
ABCA1, with a trend for down-regulation in Lean fish fed VO compared to FO and an up-275	  
regulation in the Fat fish. In this case, gene expression was significantly lower in the Lean group 276	  
compared to the Fat, when fed the VO diet. Agreement between the RT-qPCR and microarray 277	  
results initially proved problematic for EL and LPL but, on closer examination, multiple transcripts 278	  
for both genes were identified. In the case of EL, an EST was identified in the GenBank database 279	  
(DY694576) that is 86% identical, in the aligned area, to the Atlantic salmon EL reference sequence 280	  
(NM_001140535), and this is likely to have resulted in cross-hybridisation in the microarray. 281	  
Indeed, an initially tested primer pair showed very similar fold changes as those obtained in the 282	  
microarray experiment and was later found to have amplified both sequences. When RT-qPCR was 283	  
repeated using primers specific for NM_001140535, quite different results were obtained, with 284	  
significant up-regulation being observed in both Lean and Fat families fed VO compared to FO. On 285	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the other hand, determination of LPL expression was initially performed using a primer pair 286	  
available in the literature (here termed LPLa) but this resulted in a pattern of expression not 287	  
corresponding to the microarray results. Further investigation revealed that the three LPL clones in 288	  
the microarray significant interaction list correspond to two different clusters (DFCI-The Gene 289	  
Index Project; http://compbio.dfci.harvard.edu/tgi/tgipage.html), TC67836 and TC84899, which are 290	  
85 % identical to each other in the aligned region (90 % query coverage), and which we here named 291	  
LPLb and LPLc, respectively. The published LPLa primers amplify a sequence corresponding to 292	  
TC91040, which does not align with TC sequences from LPLb or LPLc. The primers designed for 293	  
LPLb and LPLc gave comparable results to the microarray experiment, and broadly similar to each 294	  
other, with a trend for down-regulation in Lean fish when fed the VO diet instead of FO and an up-295	  
regulation (significant for LPLc) in Fat fish fed the VO diet. In both cases, this was associated with 296	  
a significantly lower expression of these transcripts in Lean, compared to the Fat group, when fish 297	  
were fed the VO diet. 298	  
From the RT-qPCR analysis of other genes involved in cholesterol biosynthesis, only 299	  
mevalonate kinase (MEV) showed a pattern of expression broadly similar (in terms of up/down-300	  
regulation) to IPI (Table 3). The expression of the regulatory transcript sterol-responsive element-301	  
binding protein 2 (SREBP2) also showed the same general trends observed in IPI, MEV (Table 3) 302	  
and SQLE (Table 2), with a pronounced up-regulation in the Lean fish when VO replaced FO in the 303	  
diet, coupled with lower expression in Lean salmon, compared to Fat, when fed FO. 304	  
The microarray experiment had indicated potential differential regulation of fatty acid β-305	  
oxidation in Lean and Fat families, as suggested by the presence of three genes in the significant 306	  
interaction list, although with marginal fold changes. To verify this, we assayed the relative levels 307	  
of expression of two genes involved in the β-oxidation pathway, including acyl-CoA oxidase 308	  
(ACO), and carnitine palmitoyl tranferase 1 (CPT1), responsible for facilitating the transfer of long 309	  
chain fatty acids into the mitochondria and thus a common indicator of β-oxidation (16). However, 310	  
no significant changes were observed for these genes.   311	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To further analyse physiological mechanisms related to lipoprotein metabolism, quantification of 312	  
apolipoprotein genes (ApoAI, ApoCII and ApoB) and lipoprotein receptors (SR-BI-scavenger 313	  
receptor class B type 1 and LDLR-low density lipoprotein receptor) was performed. In general, 314	  
dietary FO replacement by VO tends to increase the expression of the three apolipoproteins and to 315	  
reduce that of the two lipoprotein receptors assayed in both experimental fish groups. However, few 316	  
statistically significant differences were observed, apart from significantly lower expression of 317	  
ApoAI and SR-BI in the Lean group, compared to Fat, when fed VO.  318	  
To fully ascertain the effects of the factors “diet” and “family” on gene expression, data were 319	  
also expressed as normalised values that could be analysed by two-way ANOVA (Fig. 1). A 320	  
significant dietary effect was observed in the expression of ApoAI, EL and LPLc, with the VO diet 321	  
inducing a higher level of expression of these genes (Fig. 1G, L and O). In addition, a significant 322	  
family effect was also observed in ApoAI and LPLc expression, with higher levels of transcripts 323	  
being measured in Fat fish compared to Lean. In both cases, and particularly for LPLc, the Fat-VO 324	  
group presented the highest up-regulation, and thus had the greatest influence. Finally, LPLb 325	  
showed significant interaction as a result of the lowest and highest levels of expression being 326	  
measured in Lean-VO and Fat-VO, respectively (Fig. 1N). 327	  
 328	  
Lipid biochemical composition of plasma, lipoprotein classes, liver and flesh 329	  
To assess possible biochemical consequences of altered gene expression, total lipid levels and 330	  
lipid class composition of liver and flesh, and cholesterol and TAG in plasma and lipoproteins 331	  
(VLDL, LDL and HDL) 24 hours after the last meal were analysed (Tables 4 and 5). Plasma 332	  
cholesterol was significantly affected by diet, with higher levels found in fish fed FO independent 333	  
of family (Table 4). Cholesterol in VLDL showed significant interaction, due to nearly doubling in 334	  
Lean fish fed FO, with no difference between the other groups. A significant family effect was 335	  
measured for plasma and LDL-TAG, with the Lean group showing significantly higher levels of 336	  
TAG than the Fat group (Table 4). In liver, significantly lower proportions of TAG, and 337	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correspondingly higher percentages of phospholipids and sterols, were found in fish fed FO 338	  
independent of family (Table 5). Significantly higher relative phospholipid level was also found in 339	  
flesh of fish fed FO but, contrary to liver, the relative level of sterols was significantly higher in 340	  
both family groups fed VO. In addition, a significant family effect was observed in flesh 341	  
phospholipids, with higher levels in the Fat group.  342	  
 343	  
Discussion 344	  
 345	  
Microarray analysis of the liver transcriptome of Atlantic salmon from two family groups, Lean 346	  
or Fat, fed diets containing either FO or VO, returned a high number of genes involved in lipid and 347	  
lipoprotein pathways showing significant interaction between genotype and diet. Considering the 348	  
roles of some of these transcripts and the possibility for functional relationships, we hypothesise 349	  
that some of the expression changes are interrelated. This prompted further investigation of the 350	  
expression of genes involved in cholesterol homeostasis, including cholesterol biosynthesis and 351	  
cellular efflux and in the regulation of these pathways, as well as some implicated in fatty acid β-352	  
oxidation and lipoprotein metabolism, including apolipoproteins, membrane lipoprotein receptors 353	  
and lipases. The gene expression data are discussed in relation to plasma, lipoprotein, liver and flesh 354	  
compositions, advancing our knowledge on how dietary VO, with altered PUFA and cholesterol 355	  
content, may alter lipid metabolism and transport and how these effects may depend on genetic 356	  
background.  357	  
 358	  
Cholesterol metabolism 359	  
Replacing FO with VO reduced plasma cholesterol in both family groups, which can be 360	  
explained by the typically lower level of cholesterol in VO compared to FO. In addition, some VO 361	  
are naturally rich in phytosterols, which reduce plasma cholesterol, LDL-cholesterol and LDL-TAG 362	  
in brook trout (Salvelinus fontinalis) (24), and LDL-cholesterol in humans, by inhibiting intestinal 363	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cholesterol absorption (25). Similarly, the lipid composition of liver, with higher levels of sterol in 364	  
fish fed FO, probably also reflects dietary cholesterol intake. 365	  
Previously in Atlantic salmon, up-regulation of SREBP2 and genes involved in cholesterol 366	  
biosynthesis was observed and attributed to lower dietary cholesterol supply by VO diets (16). In that 367	  
study, apart for HMG-CoA, which was not significantly regulated, cholesterol biosynthesis genes 368	  
and SREBP2 were all over 2-fold up-regulated in VO in relation to FO. In the present study a clear 369	  
response in terms of cholesterol biosynthesis genes was not observed and fold-changes were lower. 370	  
Although not determined, dietary cholesterol levels likely varied in the diets in the two studies and 371	  
the differential in supply between FO and VO diets might have been larger in the previous study (16). 372	  
On the other hand, a blend of VO, formulated to resemble more closely FO in terms of fatty acid 373	  
composition (13), rather than single VOs as previously (16), may have resulted in a dietary fatty acid 374	  
composition with less effect on cholesterol biosynthesis. Nonetheless, gene expression data indicate 375	  
that cholesterol biosynthesis may be up-regulated in the Lean family group when VO replaces FO, 376	  
whereas this pathway does not appear to be affected in Fat fish. Consistent with this, the expression 377	  
of SREBP2, which in mammals is positively correlated and induces the expression of all 12 378	  
enzymes of the cholesterol biosynthetic pathway (26), shows a greater increase in the Lean fish, 379	  
compared to the Fat group, when VO replaces FO. This reinforces the hypothesis that, similar to 380	  
mammals, regulation of cholesterol biosynthesis in fish is at least partly mediated by SREBP2 (16). 381	  
In addition, these differences between family groups seem to arise mostly when feeding the more 382	  
“natural” FO diet containing higher cholesterol, with the Lean fish showing a tendency for a greater 383	  
down-regulation of cholesterol biosynthesis genes. On the other hand, low dietary supply of 384	  
cholesterol has been reported to activate SREBP2 that down-regulates ABCA1 transcription and 385	  
cholesterol efflux in mice liver and human vascular endothelial cells (11,27,28). This was not obvious 386	  
in salmon but circumstantial evidence from the gene expression data indicates that, if such a 387	  
response exists, it may only occur in the Lean family group, since a trend for an inverse relationship 388	  
between SREBP2 and ABCA1 expression when VO replaces FO was only observed in this group 389	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and, furthermore, a significant down-regulation of the ABCA1 transporter was measured in the 390	  
Lean family, compared to Fat fish, when these were fed VO. Therefore, these data suggest that Lean 391	  
fish might be more responsive to dietary cholesterol and adjust the level of expression of genes 392	  
involved in cholesterol metabolism and transport more tightly than the Fat family. 393	  
 394	  
Lipoprotein synthesis and hepatic TAG metabolism 395	  
Previous studies in rainbow trout and Atlantic salmon found a significant reduction in plasma 396	  
cholesterol and LDL levels, as well as a trend towards lower VLDL levels, when VO replaced 397	  
dietary FO (4,29). In the present study, VLDL-cholesterol levels showed a diet × family interaction 398	  
with a reduction observed when VO replaced dietary FO, but only in the Lean group. In contrast, no 399	  
effects were observed in LDL-cholesterol, while LDL-TAG was affected by family, with higher 400	  
levels in the Lean group. However, a dietary trend was observed with lower levels of LDL 401	  
associated with the VO diet. Together, these results indicate a tendency towards reduced levels of 402	  
plasma cholesterol, VLDL and LDL as a result of the replacement of FO by VO in salmonids, as a 403	  
result of differences in cholesterol levels and relative levels of n-3/n-6 PUFA in these oils.  404	  
Salmon in the Fat group had lower plasma TAG and LDL-TAG compared to the Lean family 405	  
irrespective of diet. Reduced levels of VLDL and LDL-TAG in mammals can be caused by several 406	  
complex and interrelated factors (30). Analogies have been established between teleost and 407	  
mammalian lipoprotein metabolism (31,32) but we can only speculate that regulatory mechanisms are 408	  
equivalent. On one hand, decreased circulating TAG may be related to decreased hepatic VLDL 409	  
synthesis and secretion to the circulation that may be a consequence of lower availability of 410	  
precursor TAG. However, in the present study, liver lipid composition was affected by diet but not 411	  
family, suggesting that differences between the families in circulating TAG might be influenced by 412	  
differences in uptake by peripheral tissues rather than hepatic lipid metabolism. The 413	  
hypotriglyceridemic effect of dietary FO has been established in mammals and is believed to result 414	  
from a coordinated effect of n-3 LC-PUFA (particularly EPA) in suppressing hepatic lipogenesis 415	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and enhancing fatty acid oxidation in liver and muscle through inhibition of SREBP-1c and 416	  
peroxisome proliferator-activated receptor (PPAR) activation, respectively (33-35). As previously 417	  
observed in salmon (29,36), PL/TAG ratios were affected by diet with FO inducing lower TAG and 418	  
correspondingly higher PL, which is attributed to similar hypotriglyceridemic mechanisms of n-3 419	  
LC-PUFA in FO as those described in mammals. Consistent with this, lower expression of fatty 420	  
acid synthase (FAS), which plays a key role in lipogenesis, was measured in fish fed FO, 421	  
independent of family (S Morais, unpublished results). On the other hand, microarray data 422	  
suggested an interaction between diet and family affecting hepatic β-oxidation (CRAT, ECH1 and 423	  
ECHS1) and the expression of AMPK, a metabolic “sensor” responsible for regulating energy 424	  
homeostasis (37). However, fold changes were marginal and when expression of β-oxidation genes 425	  
ACO and CPT1 was assessed by qPCR there were no differences between diet or family groups.  426	  
 427	  
Lipoprotein uptake and reverse cholesterol transport 428	  
Another possible mechanism to affect circulating levels of TAG and lipoproteins is through 429	  
lipoprotein uptake by liver and peripheral tissues. Gene expression was only assessed in liver, 430	  
which does not enable assessment of uptake by peripheral tissues, given that some genes are 431	  
regulated in a tissue-specific manner (e.g., mammalian and fish LPL; 38-41). A likely explanation for 432	  
the observed differences in circulating TAG in the two family groups might be related to their lipid 433	  
storage phenotype. Hence, decreased circulating lipids 24 h after the last meal in the Fat family 434	  
group may be due to more efficient uptake of lipids by muscle and viscera, as indicated by higher 435	  
lipid contents in these tissues (13). However, this might only partly explain the results as diet × 436	  
family interaction was observed, and the family phenotype (Fat-Lean) was only maintained at the 437	  
end of the trial in fish fed FO. On the other hand, a higher level of sterols was found in flesh of fish 438	  
from both groups fed VO, which could be explained by higher uptake of LDL. Another possibility 439	  
could be a decreased rate of reverse cholesterol transport from peripheral tissues to liver when fish 440	  
are fed VO that could be linked to decreased dietary cholesterol levels and induced hepatic 441	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cholesterol synthesis (16). Nonetheless, neither diet nor genetic background affected HDL 442	  
composition in the present study, as was also reported previously (4,29). Dietary FO has been 443	  
associated with enhanced reverse cholesterol transport in mammals but Davidson (35) hypothesised 444	  
that, since n-3 LC-PUFA can stimulate simultaneously four metabolic nuclear receptors, the net 445	  
effect may result in only minimal changes in HDL levels. 446	  
A key step in VLDL and LDL clearance is lipoprotein-TAG lipolysis ahead of receptor-mediated 447	  
endocytosis. The microarray data indicated a possible interaction between diet and family in the 448	  
regulation of LPL and EL. Noteworthy was the change in expression of an angiopoietin-like 4 449	  
cDNA that has been found to inhibit LPL in mammals (42) and thus a similar relationship might exist 450	  
in fish. The qPCR analysis revealed a trend for up-regulation of LPLb and LPLc when salmon were 451	  
fed VO but only in the Fat group. In Lean salmon, where differences in VLDL content related to 452	  
diet were observed, LPL was either not affected (LPLa and LPLc) or down-regulated (LPLb) by the 453	  
VO diet. LPL is believed to be regulated at the transcriptional level and therefore these results are 454	  
likely to reflect enzyme activity (38). Conversely, expression of EL was up-regulated in both family 455	  
groups fed the VO diet. This enzyme has mainly a PL-hydrolysing activity in mammals and higher 456	  
activity towards HDL although it hydrolyses all classes of lipoproteins (43,44). Taken together, these 457	  
mechanisms may result in higher levels of circulating VLDL and LDL in fish fed FO with more 458	  
marked effect in Fat fish, opposite to what was observed. 459	  
The expression of ABCA1 also responded differently to diet depending on the genetic 460	  
background of the fish with a trend for lower expression in the Lean fish fed VO, compared to FO. 461	  
ABCA1 is a membrane transporter with roles in HDL synthesis and reverse cholesterol transport 462	  
and thus this result may be related to either HDL metabolism or cholesterol biosynthesis (27). 463	  
However, its involvement in VLDL and LDL metabolism has recently been shown with deletion of 464	  
the ABCA1 gene leading to increased VLDL production and elevated plasma TAG accompanied by 465	  
enhanced LDL clearance through overexpression of hepatic LDLR (45). Although we cannot exclude 466	  
the possibility of increased clearance rate of LDL in Lean salmon fed VO, this does not appear to 467	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involve hepatic LDLR as the expression of this gene was not affected. Another lipoprotein receptor 468	  
implicated in the metabolism of apoB-containing lipoproteins is SR-BI. Although mainly known for 469	  
selective uptake of HDL cholesterol, SR-BI has been shown to affect VLDL secretion in mice, even 470	  
if effects are not consistent (46,47). In the present study we did not detect changes in SR-BI 471	  
expression in salmon when examining the effect of diet in both family groups.  472	  
An interesting observation was that differences in gene expression between family groups were 473	  
more apparent in fish fed VO. In particular, there was a different response to dietary VO inclusion 474	  
in HDL metabolism, as several genes implicated in HDL synthesis and uptake (ABCA1, ApoAI and 475	  
SR-BI) had lower expression in the Lean group compared to Fat salmon fed VO. Expression of 476	  
apoAI was affected by both factors, diet (VO>FO) and family (Fat>Lean). ABCA1 initiates the 477	  
formation of mature HDL by facilitating cellular efflux of PL and cholesterol for lipidation of 478	  
apoAI and apoE, and its overexpression in transgenic mice can result in an anti-atherogenic plasma 479	  
profile (48). In addition, it increases flux of cholesterol to the liver through enhanced reverse 480	  
transport from peripheral tissues (27). SR-BI also stimulates reverse cholesterol transport by 481	  
mediating the selective cellular uptake of cholesteryl esters from HDL, transport of HDL-482	  
cholesterol into bile for excretion, and recycling of apolipoproteins, particularly in hepatic and 483	  
steroidogenic cells (49). Finally, LPL and EL can both influence lipoprotein metabolism by 484	  
catalysing the hydrolysis of TAG and PL, respectively, thus facilitating lipoprotein catabolism and 485	  
clearance (39,43). Again, Lean fish fed the VO diet showed lower LPLa and LPLb expression, and a 486	  
trend for reduced EL expression, than the corresponding Fat family group. This correlates well with 487	  
the expression of SR-BI and also LDLR, which might be expected to be similarly regulated to 488	  
catabolise the delipidated HDL and LDL particles after the action of LPL and EL (44). The gene 489	  
expression results thus suggest that the Fat family group might have faster lipoprotein turnover 490	  
when fed VO but the physiological and health effects of this, including the development of 491	  
arteriosclerotic changes when VO replaces FO, requires elucidation (6,7).  492	  
 493	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Lipoprotein lipase transcripts are differentially regulated in liver in response to diet 494	  
This work has also emphasised the need for caution in future studies when assaying expression 495	  
of LPL (and possibly EL), as several transcripts may exist, with different patterns of nutritional 496	  
regulation. Whereas the expression of LPLa, corresponding to the gene assayed previously (50), was 497	  
not affected by either diet or family, a strong diet × family interaction was found for LPLb and 498	  
LPLc, with LPLc expression also affected by both diet and family. In mammals, LPL is only 499	  
expressed in extrahepatic tissues (39), whereas fish also show relatively strong expression in liver 500	  
(38,41,51). Hepatic LPL expression was investigated in red sea bream, Pagrus major, where it was 501	  
shown that dietary fatty acids exert a regulatory effect on mRNA expression, although the effect 502	  
depended on feeding status and could not be solely linked to fatty acid unsaturation (51). In the 503	  
present study the VO diet, containing higher oleic and linolenic acid levels (13), induced a similar 504	  
response as in red sea bream (51) only in the Fat group and for LPLb and LPLc. It therefore appears 505	  
that the fatty acid composition of the diet may regulate LPL expression but this may depend on 506	  
genetic background. Two LPL genes were reported in red sea bream (41). The existence of more than 507	  
one LPL gene in salmon was therefore not surprising, particularly in a species that has undergone a 508	  
whole genome duplication event (52). More interesting is that the LPL transcripts appear to be 509	  
differentially regulated in liver, even if expressed at broadly comparable levels. Apart from its role 510	  
in lipid uptake and lipoprotein catabolism, LPL activity has an important function in providing non-511	  
esterified fatty acids and 2-monoacylglycerols for tissue utilisation, either storage or oxidation, 512	  
depending on tissue and nutritional state (39). Consequently, LPL is subject to tissue-specific 513	  
regulation, with reciprocal changes often being measured in response to diet composition and 514	  
physiological changes, both in mammals and fish (38-41,51). Thus, different transcripts may have 515	  
evolved to respond to particular nutritional conditions in tissues with specific metabolic functions 516	  
and demands. 517	  
 518	  
Conclusions 519	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The present study suggests that FO replacement by VO in salmon feeds can be accomplished 520	  
without major detrimental changes in cholesterol and lipoprotein metabolism. A potential effect, 521	  
associated with changes in dietary levels of n-3 LC-PUFA and cholesterol, may be a reduction in 522	  
circulating apoB-containing lipoproteins, although mechanisms remain elusive. However, the 523	  
genetic background of the fish may affect the physiological response to VO diets, although 524	  
differences in gene expression were often quite subtle. Therefore, other mechanisms of regulation in 525	  
addition to transcriptional, and affected by genetic factors (e.g., genetic variants inducing  526	  
modifications of protein activity or specificity), may be responsible for the observed differences in 527	  
tissue, plasma and lipoprotein lipid composition. In general, however, we can conclude that when 528	  
salmon were fed VO the expression of genes considered anti-atherogenic in mammals was higher in 529	  
the Fat fish, compared with the Lean fish. This was associated with significantly lower levels of 530	  
plasma TAG and LDL-TAG in the Fat group, independent of diet, whereas plasma cholesterol 531	  
likely reflected dietary intake in both family groups. In contrast, differences in VLDL and LDL 532	  
between FO and VO fed fish were only obvious in Lean fish, given that in Fat fish levels of apoB-533	  
containing lipoproteins were low and comparable to those fed VO in both groups. Lean fish also 534	  
showed a stronger response in the cholesterol biosynthesis pathway, mediated by SREBP2, to 535	  
dietary lipid composition.  536	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Table 1. Primers used for RT-qPCR.  
Transcript Primer name Primer sequence Amplicon  Tm Accession No. Source 
HMG-CoA HMG-1F 5’-CCTTCAGCCATGAACTGGAT-3’ 224 bp 60ºC TC102374 2 Leaver et al. (2008) 
 HMG-1R 5’-TCCTGTCCACAGGCAATGTA-3’     
MEV MEV-1F 5’-CCCTTAATCAGGGTCCCAAT-3’ 247 bp 60ºC DW005667 1 Leaver et al. (2008) 
 MEV-1R 5’-GGTGCTGGTTGATGTCAATG-3’     
IPI 23-3p jbt1F 5’-ACAGCCCTATGGTTATGTGTCATCTC-3’ 230 bp 60ºC CK875291 1 Leaver et al. (2008) 
 23-3p jbt1R 5’-CAAGGTGAGGCGAATGTTTGAAC-3’     
DHCR7 7DCHR-1F 5’-CTTCTGGAATGAGGCATGGT-3’ 230 bp 60ºC TC99602 2 Leaver et al. (2008) 
 7DCHR-1R 5’-ACAGGTCCTTCTGGTGGTTG-3’     
SREBP2 SREBP2-1F 5’-GACAGGCACAACACAAGGTG-3’ 215 bp 60ºC DY733476 1 Leaver et al. (2008) 
 SREBP2-1R 5’-CAGCAGGGGTAAGGGTAGGT-3’     
ABCA1 ABCA1-UTR-F2 5’- GGACGAACCCTGTGTCTGTT -3’ 203 bp 60ºC EG836783 1 New design 
 ABCA1-UTR-R2 5’- ATTTGCATTGCGTTTCAGTG -3’     
CPT1 CPT1-1F 5’-CCTGTACCGTGGAGACCTGT-3’ 212 bp 60ºC AM230810 1 Leaver et al. (2008) 
 CPT1-1R 5’-CAGCACCTCTTTGAGGAAGG-3’     
ACO ACO-2F 5’-AAAGCCTTCACCACATGGAC-3’ 230 bp 60ºC TC49531 2 Leaver et al. (2008) 
 ACO-2R 5’-TAGGACACGATGCCACTCAG-3’     
apoAI SsApoAI-F1 5’-CCATCAGCCAGGCCATAAA-3’ 73 bp 60ºC CB506105 1 Kleveland et al. (2006) 
 SsApoAI-R1 5’-TGAGTGAGAAGGGAGGGAGAGA-3’     
apoCII SsApoCII-F1 5’-GGAACCAGTCGCAGATGTTGA-3’ 145 bp 60ºC DN047858 1 Kleveland et al. (2006) 
 SsApoCII-R1 5’-TGAGGACATTCGTGGCCTTC-3’     
apoB100 SsApoBfQ 5’-AGCCTTCGATGCTGTCGGCCA-3’ 153 bp 60ºC TC79364 2* New design 
 SsApoBrQ 5’-AGGAGCACAGGCAGGGTGGTT-3’     
SR-BI SsSRBI-F1 5’-AACTCAGAGAAGAGGCCAAACTTG-3’ 204 bp 60ºC DQ266043 1 Kleveland et al. (2006) 
 SsSRBI-R1 5’-TGCGGCGGTGATGATG-3’     
LDLR SsLDLR-F1 5’-GCATGAACTTTGACAATCCAGTGTAC-3’ 78 bp 60ºC AJ003118 1 Kleveland et al. (2006) 
 SsLDLR-R1 5’-TGGAGGAGTGCCTGCTGATAT-3’     
EL SsEL-F4 5’-CCGGTGCTGCTGGAGGAAGC-3’ 378 bp 60ºC NM_001140535 1 New design 
 SsEL-R5 5’-CGACATGCAGGTCATCGGT-3’     
LPLa SsLPL-F1 5’-TGCTGGTAGCGGAGAAAGACAT-3’ 114 bp 60ºC BI468076 1** Kleveland et al. (2006) 
 SsLPL-R1 5’-CTGACCACCAGGAAGACACCAT-3’     
LPLb SsLPL-F4 5’-GGCAGCCCTACATGATAACC-3’ 172 bp 60ºC TC67836 2*** New design 
 SsLPL-R4 5’-TCTGTCCAAAGCCACTCACA-3’     
LPLc SsLPL-F6 5’-AGGGCGTTAATCCATGTCAG-3’ 223 bp 60ºC TC84899 2 New design 
 SsLPL-R6 5’-GACCTTTCAAAAGGGCATGA-3’     
Reference genes:      
Elf-1α ELF-1A jbt2 5’-CTGCCCCTCCAGGACGTTTACAA-3’ 175 bp 60ºC AF321836 1 Leaver et al. (2008) 
 ELF-1A jbt2 5’-CACCGGGCATAGCCGATTCC-3’      
β-actin BACT-F 5’-ACATCAAGGAGAAGCTGTGC-3’ 141 bp 56ºC AF012125 1 Leaver et al. (2008) 
 BACT-R 5’-GACAACGGAACCTCTCGTTA-3’     
Cofilin-2 B2F 5’-AGCCTATGACCAACCCACTG-3’ 224 bp 60ºC TC63899 2  Leaver et al. (2008) 
 B2R 5’-TGTTCACAGCTCGTTTACCG-3’     
1 GenBank (http://www.ncbi.nlm.nih.gov/) 
2 Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi/) 
* Primer was designed in the region of the sequence corresponding only to the C terminal half of ApoB-100 (i.e., not containing the N-terminal region which is common to ApoB-48) 
** Corresponding to TC91040 (Atlantic salmon Gene Index), which does not align with TC sequences from LPLb or LPLc.  
*** TC67836 (LPLb) and TC84899 (LPLc) have 85% identity in the aligned region (90% query coverage). 
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Table 2. Genes involved in lipid metabolism whose expression in the liver transcriptome 
showed a significant diet × family interaction (identified by two way-ANOVA), revealing 
transcripts whose level of expression is dependent on the combined effects of both factors. 
Indicated are also the accession numbers for each clone; the expression ratios between fish 
fed VO and those fed FO, for each one of the families, and between Lean and Fat fish fed 
either FO or VO; the p-value; and the position of the feature in the interaction list (n= 529 
total features) ordered by ascending p-value. 
Accession  Gene VO/FO  Lean/Fat  p- Position in  
no  Lean Fat  FO VO  value Sig. list 
BM413891 Angiopoietin-like 4 1.4 - 1.1  - 1.2 1.3  0.0010 13 
CK890036 Lipoprotein lipase - 1.3 1.6  1.4 - 1.5  0.0026 20 
CO470568 Lipoprotein lipase - 1.1 1.3  1.2 - 1.2  0.0033 28 
CO472476 Lipoprotein lipase - 1.2 1.7  1.2 - 1.7  0.0045 38 
BI468033 ATP-binding cassette sub-family A member 1  - 2.0 1.1  - 1.0 - 2.2  0.0051 45 
CK883097 5'-AMP-activated protein kinase (AMPK) subunit gamma-3  - 1.0 1.8  1.1 - 1.6  0.0053 46 
CK875291 Isopentenyl-diphosphate isomerase 2.0 - 1.2  - 1.9 1.3  0.0055 49 
CK894278 Carnitine O-acetyltransferase 1.2 - 1.2  - 1.2 1.2  0.0056 50 
EG648040 Acyl-Coenzyme A-binding protein  1.7 1.0  - 1.5 1.1  0.0103 89 
CK880279 Delta3,5-delta2,4-dienoyl-CoA isomerase 1.2 - 1.1  - 1.3 1.1  0.0128 114 
BM414066 Endothelial lipase precursor  - 1.2 1.2  - 1.1 - 1.6  0.0166 145 
BM414094 Phosphatidylethanolamine N-methyltransferase 1.2 - 1.4  - 1.5 1.1  0.0167 147 
GU294485 Delta-5 fatty acyl desaturase 2.1 1.2  - 1.7 1.0  0.0179 159 
CK879648 Squalene monooxygenase  (Squalene epoxidase) 1.9 1.1  - 1.9 - 1.1  0.0224 215 
AJ425698 Acetyl-CoA acetyltransferase 2 1.1 - 1.1  - 1.1 1.1  0.0244 238 
AY736067 Delta-6 fatty acyl desaturase 2.1 1.4  - 1.3 1.1  0.0317 320 
BM413811 Enoyl Coenzyme A hydratase 1 - 1.1 1.3  1.3 - 1.1  0.0403 420 
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Table 3. Relative analysis of gene expression (REST2008) of genes involved in cholesterol 
biosynthesis and its regulation, cholesterol transport/cellular efflux, β-oxidation and 
lipoprotein metabolism, assayed by RT-qPCR in liver of two groups of Atlantic salmon (Lean 
and Fat families), after a year of feeding diets containing either 100% FO or 100% VO. 
Values are normalised (by cofilin-2) gene expression ratios (up-regulation if >1 and down-
regulation if <1) and p-values, when each group is fed either a 100% FO or 100% VO  diet or 
when comparing each one of the groups fed either one of the diets.  
    VO/FO   Lean/Fat 
  Lean  Fat  FO  VO 
Genes   Ratio p-value   Ratio p-value   Ratio p-value   Ratio p-value 
Cholesterol biosynthesis, regulation and transport       
HMG-CoA  0.78 0.642  0.90 0.697  1.02 0.947  0.89 0.795 
MEV  1.88 0.109  0.91 0.757  0.53 0.116  1.09 0.697 
IPI  1.41 0.612  0.49 0.236  0.38 0.280  1.10 0.741 
DHCR7  1.27 0.405  1.06 0.826  0.65 0.190  0.78 0.304 
SREBP2  2.06 0.134  1.36 0.575  0.65 0.474  0.99 0.964 
ABCA1  0.78 0.504  1.67 0.111  1.12 0.841  0.52 0.016 
β-oxidation           
ACO  0.93 0.809  1.28 0.369  1.46 0.278  1.06 0.786 
CPT1  0.86 0.381  0.75 0.101  1.02 0.890  1.17 0.330 
Lipoprotein metabolism          
ApoAI  1.67 0.195  2.39 0.071  0.85 0.753  0.59 0.039 
ApoCII  1.28 0.527  1.70 0.065  1.23 0.589  0.93 0.646 
ApoB  1.40 0.443  1.84 0.152  0.87 0.791  0.66 0.076 
SR-BI  0.66 0.075  0.96 0.859  0.92 0.687  0.63 0.049 
LDLR  0.59 0.234  0.67 0.319  0.68 0.401  0.60 0.059 
EL  3.52 0.034  8.57 0.002  1.38 0.494  0.57 0.115 
LPLa  0.87 0.631  0.89 0.789  0.76 0.573  0.75 0.119 
LPLb  0.43 0.053  2.75 0.067  1.57 0.375  0.24 0.010 
LPLc   0.95 0.762   2.09 0.011    0.98  0.929    0.45  0.002 
 HMG-CoA: 3-hydroxy-3-methyl-glutaryl-CoA  reductase; MEV: Mevalonate kinase; IPI: Isopentenyl diphosphate 
isomerase; DHCR7: D- 7-dehydrocholesterol reductase; SREBP2: Sterol-responsive element-binding protein 2; ABCA1: 
ATP-binding cassette, sub-family A, member 1; ACO: acyl-CoA oxidase; CPT1: carnitine palmitoyltransferase I; 
ApoAI: Apolipoprotein AI; ApoCII: Apolipoprotein CII; ApoB100: Apolipoprotein B100; SR-BI: Scavenger receptor 
class B type 1; LDLR: Low density lipoprotein receptor; EL: Endothelial lipase; LPLa: Lipoprotein lipase , TC91040; 
LPLb: Lipoprotein lipase , TC67836; LPLc: Lipoprotein lipase, TC84899.  
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Table 4. Levels of circulating plasma (mM) or lipoprotein (VLDL, LDL and HDL; µmol/mL 
plasma) cholesterol and triacylglycerols (TAG)  in Atlantic salmon Lean and Fat families, 
determined after a year of feeding diets containing either 100% FO or 100% VO.  
Significance levels of two-way ANOVA are indicated for the factors “diet”, “family” and 
interaction “diet × family”.  
	  
 Lean  Fat  ANOVA p-value 
 FO VO  FO VO  Diet Family D×F 
 Mean SD Mean SD  Mean SD Mean SD     
Cholesterol             
Plasma  8.87 0.66 6.92 0.15  8.10 0.80 6.87 0.23  0.014 0.340 0.396 
VLDL  0.11 0.01 0.06 0.00  0.06 0.02 0.06 0.01  0.062 0.075 0.046 
LDL 0.96 0.10 0.65 0.10  0.64 0.17 0.55 0.12  0.089 0.080 0.278 
HDL 5.91 0.45 6.11 0.94  6.05 2.45 5.33 0.67  0.808 0.760 0.661 
              
TAG              
Plasma  2.03 0.08 2.09 0.12  1.89 0.01 1.87 0.07  0.742 0.037 0.519 
VLDL  0.22 0.05 0.16 0.00  0.16 0.01 0.18 0.02  0.371 0.287 0.107 
LDL 0.45 0.01 0.40 0.02  0.39 0.01 0.37 0.02  0.068 0.018 0.265 
HDL 2.63 0.15 2.59 0.29  2.48 0.96 2.28 0.22  0.766 0.562 0.845 
 
Table 5. Liver and flesh total lipids (g/100g of wet weight) and lipid class composition (% 
total lipid) in Atlantic salmon Lean and Fat families, determined by thin-layer lipid 
chromatography (TLC), after a year of feeding diets containing either FO or VO. Steryl esters 
were not detected in flesh. 
 Lean  Fat  ANOVA p-value 
 FO VO  FO VO  Diet Family D×F 
 Mean SD Mean SD  Mean SD Mean SD     
Liver             
Total lipids 4.0 0.3 4.1 0.1  3.4 0.1 4.8 0.4  0.015 0.799 0.024 
Phospholipids 44.3 0.6 38.3 0.6  46.7 2.0 36.9 2.9  0.000 0.608 0.057 
Triacylglycerols 29.8 0.8 37.6 2.2  26.7 3.1 39.8 3.8  0.000 0.776 0.072 
Free fatty acids 2.0 0.3 1.8 1.0  2.9 0.9 1.7 0.4  0.082 0.298 0.204 
Sterols 15.3 0.2 12.8 0.5  14.4 0.5 12.4 1.0  0.000 0.058 0.420 
Steryl esters 7.1 1.2 7.2 1.7  8.5 1.5 6.9 2.4  0.408 0.574 0.348 
              
Flesh              
Total lipids 11.6 0.2 12.8 0.3  13.2 0.2 12.9 0.2  0.050 0.006 0.010 
Phospholipids 13.3 0.2 11.3 0.9  14.4 1.1 12.4 0.7  0.000 0.016 0.942 
Triacylglycerols 74.1 1.4 74.6 1.1  72.5 2.8 73.7 0.5  0.326 0.153 0.683 
Free fatty acids 5.6 1.0 5.0 0.8  5.7 1.0 5.7 0.5  0.438 0.402 0.485 
Sterols 7.0 0.5 9.1 0.5  7.4 1.0 8.2 0.5  0.001 0.482 0.090 
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Figure legends 
 
Fig. 1. Normalised gene expression levels (obtained by dividing the number of copies of the 
target gene by the number of copies of cofilin-2) of genes involved in cholesterol biosynthesis 
and its regulation, cholesterol transport/cellular efflux and lipoprotein metabolism, 
determined by RT-qPCR in liver of two groups of Atlantic salmon (Lean and Fat families), 
after a year of feeding diets containing either 100% FO or 100% VO. A- 3-hydroxy-3-
methyl-glutaryl-CoA reductase (HMG-CoA); B- Mevalonate kinase (MEV); C- Isopentenyl 
diphosphate isomerase (IPI); D- 7-dehydrocholesterol reductase  (DHCR7); E- Sterol-
responsive element-binding protein 2 (SREBP2); F- ATP-binding cassette, sub-family A, 
member 1 (ABCA1); G- Apolipoprotein AI (apoAI); H- Apolipoprotein CII (apoCII); I- 
Apolipoprotein B100 (apoB100); J- Scavenger receptor class B type 1 (SR-BI); K- Low 
density lipoprotein receptor (LDLR); L- Endothelial lipase (EL); M- Lipoprotein lipase, 
TC91040 (LPLa); N- Lipoprotein lipase, TC67836 (LPLb); O- Lipoprotein lipase, TC84899 
(LPLc). Significance levels of two-way ANOVA are indicated for the factors “diet”, “family” 
and interaction “diet x family”, when p<0.05 (ns, not significant).  
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